# US 11,896,611 B1 · Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,896,611 B1
- Document ID: US11896611B1
- Status: Granted
- Kind: B1
- Application number: 18/094,541
- Filed: 2023-01-09
- Granted: 2024-02-13
- Earliest claimed: 2020-04-14
- Applicants: David A. Cuddeback; Thomas J. Lynch
- Inventors: David A. Cuddeback; Thomas J. Lynch
- Web page: https://patentgrep.com/patent/US11896611B1

## CPC

- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 33/30: Zinc; Compounds thereof
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 31/12: Ketones
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 31/22: of acyclic acids, e.g. pravastatin
- A61K 31/225: Polycarboxylic acids
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/4525: containing a five-membered ring with oxygen as a ring hetero atom
- A61K 31/555: containing heavy metals, e.g. hemin, hematin, melarsoprol
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 36/15: Pinaceae (Pine family), e.g. pine or cedar
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/233: Bupleurum
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/324: Boswellia, e.g. frankincense
- A61K 36/328: Commiphora, e.g. mecca myrrh or balm of Gilead
- A61K 36/537: Salvia (sage)
- A61K 36/74: Rubiaceae (Madder family)
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A phytochemical and nutraceutical composition and method for protection against a wide spectrum of viral and bacterial infections, including Covid-19, and for treatment of established infection and infectious inflammation. The composition includes a novel combination of vitamin, mineral, nutraceutical and phytochemical supplements. The composition of supplements and method may be compounded as a pill, tablet, powder, capsule or liquid be taken orally one or more times per day. Vitamin C and vitamin E along with zinc complexed with pyrithione or citrate are used in conjunction with nutraceuticals and phytochemicals provided, respectively, as immune boosters and antiviral agents along with anti-inflammatory nutraceuticals and phytochemicals.

## Claims

### Claim 1

A method for treating a patient for a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, said nutraceutical portion of the composition consisting of vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include five or more of the following anti-infectious phytochemicals:
fulvic acid; echinacea purpura extract; sage extract; uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; pomegranate extract; and Radix bupleuri extract;
two or more of the following anti-inflammatory nutraceuticals:
Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA}; Alpha-lipoic acid;
five or more of the following anti-inflammatory phytochemicals):
Curcumin extract with piperine; green tea extract; Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid(—AKBA); resveratrol; Commiphora myrrha extract; uncaria tomentosa extract; extract of maritime pine bark; green tea extract
Cannabidiol (CBD).

### Claim 2 (depends on 1)

The method as in claim 1, wherein, the step of administering a nutraceutical composition to the patient containing zinc with the cofactor of methionine.

### Claim 3 (depends on 2)

The method as in claim 2, wherein the step of administering the nutraceutical composition to the patient in the effective amount of vitamin C is 1000 mg; effective amount of vitamin E is 200 mg; and the effective amount of zinc is 25 mg.

### Claim 4

A method for treating a patient for a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, said nutraceutical portion of the composition consisting of vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include five or more of the following anti-infectious phytochemicals:
fulvic acid; echinacea purpura extract, sage extract uncaria tomentosa extract Black Elderberry extract or American Elderberry extract; pomegranate extract; and Radix bupleuri extract
two or more of the following anti-inflammatory nutraceuticals:
Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA}; Alpha-lipoic acid;
five or more of the following anti-inflammatory phytochemicals
Curcumin extract with piperine; green tea extract Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid(—AKBA); resveratrol; Commiphora myrrha extract uncaria tomentosa extract extract of maritime pine bark; green tea extract Cannabidiol,
wherein, the step of administering a nutraceutical composition to the patient containing zinc with the cofactor of methionine,
wherein the step of administering the nutraceutical composition to the patient in the effective amount of vitamin C is 1000 mg; effective amount of vitamin E is 200 mg; and the effective amount of zinc is 25 mg,
wherein the step of administering the effective amount of anti-infectious nutraceuticals in the composition include five or more of the following anti-infectious phytochemicals:
a) 1000 mg fulvic acid extract
b) 800 mg Echinacea purpura
c) 800 mg Sage extract
d) 400 mg Cat's Claw extract, namely Unicaria toments
e) 200 mg Black Elderberry extract, namely Sambucus nigra or 200 mg American Elderberry extract, namely Sambucus canadensis
f) 400 mg pomegranate extract and
g) 400 mg Radix bupleuri extract and
wherein the step of administering the effective amount of anti-inflammatory phytochemicals and nutraceuticals include:
the following two anti-inflammatory nutraceuticals:
1000 mg Omega-3 fatty acids, total from eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and 200 mg Alpa-lipoic acid;
and five or more of the following anti-inflammatory phytochemicals:
400 mg curcumin extract with piperine;
300 mg Green Tea extract;
800 mg of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA);
200 mg Resveratrol;
150 mg extract of Maritime pine bark extract;
400 mg Commiphora myrrha extract; and
400 mg uncaria tomentosa extract; and
50 mg cannabidiol (CBD).
